News|Articles|March 22, 2019

In the Lab eNewsletter

  • Pharmaceutical Technology\'s In the Lab eNewsletter-04-03-2019
  • Volume 14
  • Issue 4

Laboratory Balances for Improved Operational Efficiency and Flexibility

Sartorius introduced the Cubis II portfolio of laboratory balances at Pittcon 2019 in Philaphelia, PA.

Sartorius’ Cubis II portfolio of balances for R&D and analytical laboratories offer high capacity, readability, and robust stability and accuracy for all sample types. Configurable hardware and software are fully customizable to maximize operational efficiency and experimental outcomes.

Features include the following:

  • A modular design and broad selection of capacity and readability options, draft-shield types, weighing pans, and displays enable 6000 possible hardware configurations for optimized workflows. The initial hardware configuration can be improved with additional accessories, and new software applications will be added over time, according to the company.

  • QApp software is adaptable to specific user requirements. The software’s onboard center allows direct download of protocols and creation of customized applications.

  • The balances offer easy integration with laboratory software and laboratory information management systems (LIMS), eliminating the need for separate software islands.

  • CFR part 11 and EU annex 11 paperless compliance that allows for an authenticated electronic record from data acquisition to analysis. Control over user access levels and protocols, including the ability to pull logins directly from the user’s LIMS system, ensures traceability and limits potential errors.

The balances promote intuitive operation aided by intelligent diagnostic systems. This enables increased repeatability of workflows while lowering the possibility of human error during measurement steps, according to the company. Standard operating procedures can be configured as an approved workflow.

Gerry Mackay, member of the executive board, Sartorius Lab Products and Services division, stated in a March 19, 2019 press release that the Cubis II series integrates seamlessly into existing workflows unlike universal balances, which may require a lab’s standard operating procedures to be adapted to the functionality of the balance.

The Cubis II portfolio was introduced at Pittcon 2019 in Philadelphia, PA, which runs from March 19¬–21, 2019.

Source: Sartorius


Related to this article

Quality inspector walking through processing area with stainless tanks and tablet | Image Credit: ©Surachai -stock.adobe.com
At the PDA/FDA Joint Regulatory Conference 2026, Helen Motamen, MS global head, Sanofi Quality Audit, Inspection, Intelligence & Advocacy, at Sanofi, provided advice for creating a strong internal audit program.
Intravenous therapy; drip chamber in focus against a colorful background | Image Credit: ©Anna Jurkovska -stock.adobe.com
This article explores the historical use of silicone oil in the performance of primary drug product packaging; design of experiment test results for selection of the cleaning agent and CCPs; assessment of visible residue limits and Fourier-transform infrared spectroscopy surface analysis; and setting health-based exposure limits for silicone oil using a non-uniform distribution model, and a previously published permitted daily exposure.